The One Click Group

The One Click Group
Health Advocacy

RSS Feed Follow OneClickGroup on Twitter

Dr Iain Stephenson
Found Guilty of Vaccine
Research Fraud
The One Click Group

Mobilising ME/CFS Charities
To Smash Flawed
PACE Trial Results
Lara, Health Advocate

UK Public Health
In Dire Straits
Dr Dick van Steenis MBBS

Lies Damned Lies
Swine Flu
Statistics Exposed
By Lara

Vaccination Graphs
The Awful Stats In Action
Raymond Obomsawin Ph.D

Issues In Immunization
Theory And Practice
Raymond Obomsawin Ph.D

March 2010

One Click
Of Information
UK Police Harassment
In The Internet Era

Barbara Loe Fisher
NVIC Conference
Style, Gonads
Brass Ovaries
By Jane Bryant

New Journalism
Status Quo
By Jane Bryant
NVIC Conference

How The
Judicial Review
NICE Guidelines
Was Lost
Jane Bryant
The One Click Group

Vaccines Propaganda
David Salisbury
Public Relations

David Southall
"A Very
Dangerous Doctor"
Panorama swims
with sharks
Lisa Blakemore Brown

Dr David Salisbury
Never Mind Me,
I'm Basil Fawlty!

David Salisbury
Vaccine Litigation

The Politics
And Commerce
Of Autism
By Lisa Blakemore Brown

Vaccine/Autism Case
Mitochondrial Disfunction
ME/CFS Patients

The Consensus Report
Family Law Reform

Canadian Definition of ME-CFS

The Weird World of Wikipedia
By Martin J. Walker

Click here to email us with any thoughts or opinions you wish to share about the website.


News Archives 4361-4380
Number Title Post Date
4361 Millions Of Britons At Risk From Taking Statins Drug 19/01/2011 13:15:38
4362 GlaxoSmithKline's 4 Billion Legal Costs To Date For Defective Avandia Drug 19/01/2011 13:18:24
4363 Pfizer & Others Named In St. Clair County Law Suit Over Dilantin 19/01/2011 13:20:12
4364 So Amazon, Visa, PayPal, MasterCard: Was It Worth Accepting Government Lies? 19/01/2011 13:22:42
4365 Join Anonymous And Make The Ultimate Difference 19/01/2011 13:24:38
4366 Information Web Wars Soon To Embroil Corporations 19/01/2011 13:29:14
4367 Exempt IB Claimants To Be Early ESA Transfers UK 20/01/2011 18:04:28
4368 WHO Attempts To Appoint Conflict Of Interest Pharma Executive 20/01/2011 18:08:43
4369 Stop Retaliating Against Whistleblowers - Take Action Now! 20/01/2011 18:12:14
4370 1300 Cases Of Vaccine-Related Brain Damage Compensated In US Courts 20/01/2011 18:14:06
4371 WikiLeaks' Jacob Appelbaum Detained & Searched Yet Again At Airport 20/01/2011 18:16:29
4372 Anna Ardin & Co Behind New Julian Assange Hate Campaign 20/01/2011 18:19:09
4373 WikiLeaks - Human Decency & Transparency 20/01/2011 18:22:39
4374 UK Government Interfered In Deadly BioLab Bidding Process 21/01/2011 15:40:16
4375 Medical Journals, Doctors And Ties To Hedge Funds 21/01/2011 15:46:33
4376 Sanofi Aventis Epilim Birth Defects Drug Case Dropped By Legal Aid 21/01/2011 15:48:51
4377 Elias Tembenis, Another Vaccine-Injury Case US Federal Vaccine Court Awards Damages 21/01/2011 15:53:25
4378 US Reports Flu Vaccine Seizures In Babies & Toddlers 21/01/2011 15:58:22
4379 Julian Assange Gets Visa To Visit Russia 21/01/2011 16:03:59
4380 Peter Mandelson Is A *anker 23/01/2011 10:17:12

[Previous] [Next]

WHO Attempts To Appoint Conflict Of Interest Pharma Executive
Share |

The WHO, A Novartis Exec & A Conflict Of Interest

By Ed Silverman // January 19th, 2011 

paul-herrlingLate last month, the World Health Organization proposed members for what it calls a consultative expert working group for R&D financing, which would evaluate and recommend funding for partnership projects for such problems as neglected diseases. The protocol involves nominating individuals from different countries and regions in order to create a balance reflecting varying needs and views.

But one suggested member is reportedly generating some controversy - Paul Herrling, who heads the Institutes for Developing World Medical Research at Novartis. Among the 21 people suggested for the working group, he is the only one listed as currently working as an executive for a drugmaker (see the list here). And for that reason, his nomination stirred some opposition over concerns of any potential conflict of interest.

For instance, Herrling is the author of a proposal asking the CEWG for $10 billion in grants to subsidize pharmaceutical industry research into neglected diseases (read here). He is also involved in an effort to create a revised proposal for funding partnership development projects, along with the International AIDS Vaccine Initiative. And so his nomination was questioned by representatives from Thailand, which has sparred with several brand-name drugmakers over pricing and compulsory licensing.

Consequently, the nomination has caused a debate and prompted pushback from some European members of the WHO executive board, who are threatening to hold up approving the creation of the working group, according to Knowledge Ecology International, a non-profit advocacy group that focuses on intellectual property issues that affect access to medications (look here).

This is not the first time that the WHO has encountered criticism over a decision to tap execs from drugmakers for advisory groups. Last year, the agency was embroiled over a decision to withhold the names of scientific advisors who participated on its pandemic flu panel. The names were released only after the WHO declared the pandemic had ended (read this).

Herrling, himself, may not be a huge issue, according to KEI’s Jamie Love. “Among public health groups, Paul Herrling is one of the highest regarded big pharma executives, and someone that KEI and others respect and enjoy working with. We just do not see how the WHO can have him evaluate his own funding proposals,” he writes. “We would have thought the previous controversy over the industry influence on the influenza pandemic expert group would have make the WHO more sensitive to the public’s concerns over conflicts of interest. Apparently not.”

UK Web Hosting by Thu, January 20th, 2011. 06:08 pm